Vita Life Sciences Ltd - Asset Resilience Ratio

Latest as of June 2025: 39.38%

Vita Life Sciences Ltd (VLS) has an Asset Resilience Ratio of 39.38% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$29.40 Million

≈ $20.80 Million USD Cash + Short-term Investments

Total Assets

AU$74.64 Million

≈ $52.82 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Vita Life Sciences Ltd's Asset Resilience Ratio has changed over time. Check Vita Life Sciences Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Vita Life Sciences Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Vita Life Sciences Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$29.40 Million	39.38%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$29.40 Million	39.38%

Asset Resilience Insights

Very High Liquidity: Vita Life Sciences Ltd maintains exceptional liquid asset reserves at 39.38% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Vita Life Sciences Ltd Industry Peers by Asset Resilience Ratio

Compare Vita Life Sciences Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Vita Life Sciences Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Vita Life Sciences Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	29.90%	AU$21.50 Million ≈ $15.21 Million	AU$71.89 Million ≈ $50.87 Million	-2.21pp
2023-12-31	32.11%	AU$19.20 Million ≈ $13.59 Million	AU$59.81 Million ≈ $42.32 Million	+24.68pp
2022-12-31	7.42%	AU$3.85 Million ≈ $2.72 Million	AU$51.80 Million ≈ $36.65 Million	-5.81pp
2021-12-31	13.23%	AU$5.99 Million ≈ $4.24 Million	AU$45.27 Million ≈ $32.03 Million	+2.03pp
2020-12-31	11.21%	AU$4.38 Million ≈ $3.10 Million	AU$39.10 Million ≈ $27.67 Million	+5.43pp
2019-12-31	5.77%	AU$2.11 Million ≈ $1.49 Million	AU$36.51 Million ≈ $25.84 Million	-24.86pp
2018-12-31	30.63%	AU$10.94 Million ≈ $7.74 Million	AU$35.72 Million ≈ $25.27 Million	+17.52pp
2017-12-31	13.11%	AU$4.32 Million ≈ $3.06 Million	AU$32.95 Million ≈ $23.32 Million	+7.82pp
2016-12-31	5.30%	AU$1.71 Million ≈ $1.21 Million	AU$32.36 Million ≈ $22.90 Million	+0.24pp
2015-12-31	5.05%	AU$1.64 Million ≈ $1.16 Million	AU$32.39 Million ≈ $22.92 Million	--

pp = percentage points

About Vita Life Sciences Ltd

AU:VLS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$95.85 Million

AU$135.46 Million AUD

Market Cap Rank

#19281 Global

#620 in Australia

Share Price

AU$2.48

Change (1 day)

+1.64%

52-Week Range

AU$2.16 - AU$2.83

All Time High

AU$2.83